Cameco is set to post sharply higher Q2 revenues and EPS, but an earnings beat may remain out of reach.
Key Points in This Article: The uranium sector is set to grow due to global nuclear capacity expansion and supportive U.S.
Recently, Zacks.com users have been paying close attention to Cameco (CCJ). This makes it worthwhile to examine what the stock has in store.
Cameco (CCJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cameco (CCJ) closed at $79.15 in the latest trading session, marking a +1.6% move from the prior day.
CCJ forecasts CAD 3.3-3.55 billion in 2025 revenues, fueled by pricing power and rising fuel services demand.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Cameco (CCJ) closed the most recent trading day at $77.91, moving +2.26% from the previous trading session.
The market has clearly signaled its confidence in uranium producer Cameco NYSE: CCJ. The company's stock has delivered a strong three-month performance, climbing over 80% as of mid-July 2025.
CCJ soars 41.5% YTD, backed by its upbeat uranium output guidance, bullish Westinghouse gains and long-term nuclear demand trends.
CCJ lifts Q1 uranium output by 3% and holds firm on 2025 outlook despite JV Inkai's temporary shutdown.
In the most recent trading session, Cameco (CCJ) closed at $70.82, indicating a -1.02% shift from the previous trading day.